BUSINESS ACQUISITION - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended
	Feb. 24, 2017	Mar. 31, 2017	Mar. 31, 2016
Business Acquisition [Line Items]
Equity securities, estimated fair value		$ 11,300
Acquisition adjustment expense		6,394	$ 13,419
Interest Expense, Intangible Asset Amortization, and External Expenses Related to Acquisition
Business Acquisition [Line Items]
Acquisition adjustment expense		(7,400)
Interest Expense, Intangible Asset Amortization, and External Expenses Related to Acquisition | Derma Sciences
Business Acquisition [Line Items]
Acquisition adjustment expense		(2,900)
Derma Sciences
Business Acquisition [Line Items]
Acquired deferred taxes		19,355
Deferred tax asset, federal net operating loss		39,700
Deferred tax asset, intangibles		15,800
Deferred tax liabilities, intangibles		36,800
Consideration for acquisition	$ 210,800
Payment of closing expenses	4,800
Settlement of stock compensation plan	4,300
Payments to Acquire Businesses, Net of Cash Acquired	201,700
Revenue of acquired company since acquisition		$ 10,400
BioD Earnout Payment | Derma Sciences
Business Acquisition [Line Items]
Contingent consideration range of outcomes, value, high	26,500
Contingent consideration, liability	$ 9,100
Fair Value Inputs, Revenue Volatility	13.50%
Fair value inputs, discount rate	3.00%
Product Payment Contingent Consideration | Derma Sciences
Business Acquisition [Line Items]
Contingent consideration range of outcomes, value, high	$ 29,700
Contingent consideration, liability	$ 25,900
Fair Value Inputs, Product Payment Rate	98.00%
Fair value inputs, discount rate	2.50%
Medihoney Earnout Payment | Derma Sciences
Business Acquisition [Line Items]
Contingent consideration range of outcomes, value, high	$ 5,000
Contingent consideration, liability	$ 1,300
Fair Value Inputs, Revenue Volatility	27.50%
Fair value inputs, discount rate	4.50%